Updated:
Alwyn Capital
Alwyn Capital is an early-stage asset manager led by Heather Courtney with capital from David Magerman.
Alwyn Capital
Partnering with early-stage biotech innovators to transform trillion-dollar industries and build a brighter future. | The firm backs pre-Seed and Seed stage biotechnology breakthroughs across protein innovation, next-generation materials, and advanced biological modeling that are redefining trillion-dollar legacy industries to create a more equitable and sustainable future.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Brooklyn
Corporate office
Brooklyn, United States
Principals
David Magerman
Founder
Heather Courtney
Founder / CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Alwyn Capital?
Heather Courtney serves as founding general partner and CEO. David Magerman supplies the primary capital as founder.
Where does the underlying wealth come from?
Capital originates from David Magerman, a former Renaissance Technologies executive.
What investment stages does Alwyn Capital typically target?
The firm targets early-stage opportunities.
How is Alwyn Capital related to GlassWall Syndicate?
Heather Courtney serves as a deal lead for the GlassWall Syndicate impact investment network.
Does Alwyn Capital maintain philanthropic structures?
David Magerman maintains a relationship with the Kohelet Foundation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: